Chargement en cours...
Prevalence and Clinical Impact of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolated From Hospitalized Patients
BACKGROUND: We estimated the prevalence and clinical impact of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA). The concordance between macromethod and glycopeptide resistance detection (GRD) E tests was determined. In addition, predictors of clinical outcomes in hospitalized pat...
Enregistré dans:
| Publié dans: | Ann Lab Med |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
The Korean Society for Laboratory Medicine
2016
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4773264/ https://ncbi.nlm.nih.gov/pubmed/26915612 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3343/alm.2016.36.3.235 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|